Healthcare -
Biotechnology - NASDAQ - US
$ 9.61
-17.1 %
$ 482 M
Market Cap
-3.28
P/E
RGNX - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities RGNX - REGENXBIO Inc.
103 M
LAST VALUE
226.68%
2 YEAR CAGR
2.03%
5 YEAR CAGR
0.00%
10 YEAR CAGR